136 related articles for article (PubMed ID: 1371222)
21. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate.
Tanaka N; Muro Y; Sugiura K; Tomita Y
Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in the diagnosis of systemic rheumatic diseases.
von Mühlen CA; Tan EM
Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
[TBL] [Abstract][Full Text] [Related]
23. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review.
Sontheimer RD
Photochem Photobiol; 1996 May; 63(5):583-94. PubMed ID: 8628749
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
Maddison P; Mogavero H; Provost TT; Reichlin M
J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
[TBL] [Abstract][Full Text] [Related]
25. Recently characterised autoantibodies and their clinical significance.
Sturgess A
Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
[TBL] [Abstract][Full Text] [Related]
26. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
27. [Autoantibody profile in collagen diseases. A clinical-serological study of 250 patients from Tuebingen clinics].
von Kiparski A; Stechemesser E; Berg PA
Dtsch Med Wochenschr; 1986 Aug; 111(33):1234-41. PubMed ID: 3091351
[TBL] [Abstract][Full Text] [Related]
28. PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.
Fiorentino DF; Presby M; Baer AN; Petri M; Rieger KE; Soloski M; Rosen A; Mammen AL; Christopher-Stine L; Casciola-Rosen L
Ann Rheum Dis; 2016 Jun; 75(6):1145-51. PubMed ID: 26253095
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
Hietarinta M; Lassila O
Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
[TBL] [Abstract][Full Text] [Related]
30. Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assays using affinity purified antigens. An approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus.
Venables PJ; Charles PJ; Buchanan RR; Yi T; Mumford PA; Schrieber L; Room GR; Maini RN
Arthritis Rheum; 1983 Feb; 26(2):146-55. PubMed ID: 6401995
[TBL] [Abstract][Full Text] [Related]
31. The reaction of SLE antibodies with native, single stranded RNA: radioassay and binding specificities.
Eilat D; Steinberg AD; Schechter AN
J Immunol; 1978 Feb; 120(2):550-7. PubMed ID: 340588
[TBL] [Abstract][Full Text] [Related]
32. [The clinical significance of SSA antigen and its different positive expressions].
Li YJ; Liu L; Zhang FC
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):165-8. PubMed ID: 12816697
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases.
Nakamura RM; Tan EM
Clin Lab Med; 1986 Mar; 6(1):41-53. PubMed ID: 2420510
[TBL] [Abstract][Full Text] [Related]
34. Range of antinuclear antibodies in "healthy" individuals.
Tan EM; Feltkamp TE; Smolen JS; Butcher B; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; McDougal JS; Rothfield NF; Smeenk RJ; Takasaki Y; Wiik A; Wilson MR; Koziol JA
Arthritis Rheum; 1997 Sep; 40(9):1601-11. PubMed ID: 9324014
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of B cell autoepitopes and mechanisms for autoantibody production in autoimmune diseases].
Kato T
Nihon Rinsho; 1997 Jun; 55(6):1462-7. PubMed ID: 9200933
[TBL] [Abstract][Full Text] [Related]
36. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.
Pisetsky DS
Scand J Immunol; 2012 Sep; 76(3):223-8. PubMed ID: 22670594
[TBL] [Abstract][Full Text] [Related]
37. Current concepts and advances in clinical laboratory testing for autoimmune diseases.
Hang LM; Nakamura RM
Crit Rev Clin Lab Sci; 1997; 34(3):275-311. PubMed ID: 9226106
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ro fine specificity defined by multiple antigenic peptides identifies components of tertiary epitopes.
Scofield RH; Zhang FC; Kurien BT; Harley JB
Clin Exp Immunol; 1997 Sep; 109(3):480-7. PubMed ID: 9328126
[TBL] [Abstract][Full Text] [Related]
39. Antinuclear antibodies in diagnosis and management.
Tan EM
Hosp Pract (Off Ed); 1983 Jan; 18(1):79-84. PubMed ID: 6401273
[TBL] [Abstract][Full Text] [Related]
40. [Cloning and prokaryotic expression of recombinant Jo-1 antigen and identification of its antigen specificity].
Zhao XY; Bi ZL; Wu YH; Xin HT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1170-3. PubMed ID: 19068203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
